×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| Zydus Lifesciences Limited | 53266 | 10262 | 52691 | 10.18 | 89,087 | 19.6 |
| LUPIN LTD. | 58,214.20 | 8,588.60 | 57,677.10 | 18.69 | 86976 | 30.3 |
| AUROBINDO PHARMA LTD. | 81,358.10 | 8,455.70 | 79,785.20 | 14.56 | 65341 | 18.4 |
Zydus Lifesciences Limited, with Security Code 532321, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,980.9 | 2,398.8 | 2,086.9 | 2,579.3 | 2,955.7 | 2,159.3 | 2,371.3 | 3,332.4 | 4,160.2 | 2,620.6 |
| Expenses | 1,436.6 | 1,719.8 | 1,628.3 | 1,806.8 | 1,814.7 | 1,509.9 | 1,672.2 | 1,763.2 | 1,787.3 | 1,678.4 |
| Operating Profit | 544.3 | 679.0 | 458.6 | 772.5 | 1,141.0 | 649.4 | 699.1 | 1,569.2 | 2,372.9 | 942.2 |
| OPM % | 27.48% | 28.31% | 21.98% | 29.95% | 38.6% | 30.07% | 29.48% | 47.09% | 57.04% | 35.95% |
| Other Income | 51.7 | 109.2 | 136.3 | 47.4 | 82.4 | 534.5 | 106.8 | 352.5 | 106.6 | 326.7 |
| Interest | 40.6 | 64.1 | 88.5 | 85.0 | 89.7 | 90.9 | 103.9 | 106.2 | 115.4 | 95.9 |
| Depreciation | 123.1 | 124.0 | 121.6 | 119.9 | 121.2 | 124.9 | 127.7 | 130.6 | 130.6 | 133.7 |
| Profit before tax | 432.3 | 600.1 | 384.8 | 818.8 | 1,012.5 | 968.1 | 574.3 | 1,693.5 | 2,233.5 | 1,039.3 |
| Tax % | 23.3% | 24.8% | 33.5% | 20.2% | 22.9% | 16.8% | 21.6% | 16.6% | 23.9% | 24% |
| Net Profit | 331.5 | 451.1 | 255.9 | 490.7 | 780.9 | 805.0 | 450.4 | 1,405.2 | 1,700.8 | 789.8 |
| EPS in Rs | 3.24 | 4.45 | 2.53 | 4.85 | 7.71 | 7.96 | 4.45 | 13.89 | 16.9 | 7.85 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,134.7 | 4,362.3 | 5,010.6 | 5,139.6 | 4,368.8 | 4,505.2 | 5,533.8 | 6,207.5 | 5,237.0 | 5,269.1 |
| Expenses | 3,319.4 | 3,406.3 | 3,755.0 | 3,634.3 | 3,222.7 | 3,402.8 | 3,903.3 | 4,123.5 | 3,775.6 | 3,881.5 |
| Operating Profit | 815.3 | 956.0 | 1,255.6 | 1,505.3 | 1,146.1 | 1,102.4 | 1,630.5 | 2,084.0 | 1,461.4 | 1,387.6 |
| OPM % | 19.7% | 21.9% | 25.1% | 29.3% | 26.2% | 24.5% | 29.5% | 33.6% | 27.9% | 26.3% |
| Other Income | 44.4 | 38.5 | -563.5 | 21.8 | 54.0 | 37.7 | 156.4 | 63.2 | 68.2 | 57.5 |
| Interest | 35.1 | 32.8 | 27.7 | 18.1 | 8.7 | 19.8 | 34.6 | 32.2 | 25.1 | 32.0 |
| Depreciation | 181.8 | 181.6 | 178.6 | 179.8 | 184.2 | 194.8 | 205.3 | 215.3 | 233.6 | 229.0 |
| Profit before tax | 642.8 | 780.1 | 1,087.1 | 1,343.4 | 1,007.2 | 925.5 | 1,547.0 | 1,899.7 | 1,270.9 | 1,184.1 |
| Tax % | 21.3% | 25% | 28.2% | 16.3% | 22.5% | 23.1% | 20.8% | 23% | 29.4% | 15.2% |
| Net Profit | 526.1 | 631.2 | 358.2 | 1,133.6 | 803.2 | 789.9 | 1,246.1 | 1,482.5 | 920.2 | 1,026.2 |
| EPS in Rs | 5 | 6 | 2 | 10 | 7 | 7 | 11 | 14 | 9 | 10 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | 12% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 19% |
| 3 Years: | 28% |
| TTM: | 63% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 26% |
| 3 Years: | 34% |
| 1 Year: | -4% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 8% |
| 3 Years: | 11% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 17% |
| 3 Years: | 18% |
| TTM: | 39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 26% |
| 3 Years: | 34% |
| 1 Year: | -4% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|